Correlating Ic/Pbs Symptoms With Urine Biomarkers - Tabular View

Tracking Information

First Received Date ^ICMJE

January 5, 2009

Last Updated Date

January 5, 2009

Start Date ^ICMJE

January 2009

Estimated Primary Completion Date

January 2011 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

To correlate IC/PBS symptoms with urine biomarkers [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

No Changes Posted

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Correlating Ic/Pbs Symptoms With Urine Biomarkers

Official Title ^ICMJE

Correlating Ic/Pbs Symptoms With Urine Biomarkers

Brief Summary

Completion of a brief survey tool and providing an urine specimen. The study purpose is to improve our understanding of interstitial cystitis and painful pelvic syndrome.

Detailed Description

The purpose of the study is to improve our understanding of the IC/PBS and develop new treatments. Participation in the study will allow us to compare clinical information, obtained by completion of a brief survey, with substances found in the a urine specimen that is donated to the Beaumont Biobank.

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Other, Other

Condition ^ICMJE

Interstitial Cystitis
Pelvic Syndrome

Intervention ^ICMJE

Other: No intervention

Study Arms / Comparison Groups

patients will be asked to provide a urine specimen and complete a questionnaire.

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Enrolling by invitation

Estimated Enrollment ^ICMJE

500

Estimated Completion Date

June 2011

Estimated Primary Completion Date

January 2011 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion:

Men and women with interstitial cystitis/painful bladder syndrome greater than 18 years old
Male and female controls without a history of IC/PBS diagnosis

Exclusion:

1. Unable to complete questionnaires and/or give informed consent

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Yes

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00817388

Responsible Party

Michael Chancellor, MD, Beaumont Hospitals

Study ID Numbers ^ICMJE

2008-294

Study Sponsor ^ICMJE

William Beaumont Hospitals

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Michael Chancellor, MD

William Beaumont Hospitals

Information Provided By

William Beaumont Hospitals

Verification Date

January 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP